3. Respiratory system
3.3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh
3.3.2. Leukotriene receptor antagonists
Preferred List
MONTELUKAST
Restrictions:
Use for seasonal allergic rhinitis was not accepted by SMC and this indication is non-Formulary.
Prescribing Notes:
Not currently licensed for the use in COPD
3.3.3. Phosphodiesterase type-4 inhibitors
No medicines from this class are included in the Formulary3.3.1. Cromoglicate and related therapy
Total Formulary